Table 2.

Her2/neu status in endometrial serous carcinoma, as determined by immunohistochemistry

References	Her2/neu status
	Number	0–1+	2+	3+
Slomovitz et al [107]	68	56	10	2
Santin et al [106]	26	10	7	9
Villella et al [105]	17	12	0	5
Odicino et al [108]	12	10	0	2
Singh et al [109]	45	26	13	6
Total	168	114 (67.9%)	30 (17.8%)	24 (14.3%)